Pepex Biomedical is an electrochemical biosensor company that is approaching commercialization by applying its technology to an industry-disruptive medical device that includes a diagnostic blood glucose measuring system which is wirelessly enabled to connect to the cloud. This breakthrough platform significantly improves the accuracy of glucose testing, provides users with immediate diagnostic results, and simultaneously shares the data with physicians, caregivers and insurance providers (Payers) on a real-time basis. The Company has amassed an extensive IP portfolio of over 300 global patents that protect our proprietary manufacturing process and unique biosensor design capable of detecting 800 unique biomarkers including COVID-19, Sepsis, HIV, Ebola, Hepatitis and other life-altering antigens.